Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZeniFOAM is a line of sterile polyurethane foam dressings developed by Focus Health Group for the management of moderately to heavily draining wounds. The product line includes a base non-adherent foam dressing and several silver-impregnated variants (ZeniFOAM Ag) that provide antimicrobial properties. These dressings are designed to absorb exudate, protect fragile skin, and maintain a moist wound environment to facilitate healing. Some versions feature silicone facing or adhesive borders to minimize trauma during dressing changes. The silver-infused versions contain approximately 0.25-0.35mg/cm³ of silver to prevent infection and encourage wound recovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ZeniFOAM.